1. Rayego-Mateos S, Morgado-Pascual JL, Opazo-Ríos L, Guerrero-Hue M, García-Caballero C, Vázquez-Carballo C, et al. Pathogenic pathways and therapeutic approaches targeting inflammation in diabetic nephropathy. Int J Mol Sci 2020; 21:3798-3841.
2. Afkarian M, Zelnick LR, Hall YN, Heagerty PJ, Tuttle K, Weiss NS, et al. Clinical manifestations of kidney disease among US adults with diabetes, 1988-2014. JAMA 2016; 316:602-610.
3. Fan Y, Lee K, Wang N, He JC. The role of endoplasmic reticulum stress in diabetic nephropathy. Curr Diab Rep 2017; 17:17-24.
4. Spencer BG, Finnie JW. The role of endoplasmic reticulum stress in cell survival and death. J Comp Pathol 2020; 181:86-91.
5. Xiong S, Han Y, Gao P, Zhao H, Jiang N, Sun L. AdipoRon protects against tubular injury in diabetic nephropathy by inhibiting endoplasmic reticulum stress. Oxid Med Cell Longev 2020; 2020:1-15.
6. Fan Y, Zhang J, Xiao W, Lee K, Li Z, Wen J, et al. Rtn1a-mediated endoplasmic reticulum stress in podocyte injury and diabetic nephropathy. Sci Rep 2017; 7:323-736.
7. Zhang C, Wang H, Chan GCF, Zhou Y, Lai X, Lian M. Extracellular vesicles derived from human umbilical cord mesenchymal stromal cells protect cardiac cells against hypoxia/reoxygenation injury by inhibiting endoplasmic reticulum stress via activation of the PI3K/Akt pathway. Cell Transplant 2020; 29:1-8.
8. Kumar A, Mittal R. Nrf2: a potential therapeutic target for diabetic neuropathy. Inflammopharmacology 2017; 25:393-402.
9. Sun G, Zhao Z, Lang J, Sun B, Zhao Q. Nrf2 loss of function exacerbates endoplasmic reticulum stress-induced apoptosis in TBI mice. Neurosci lett 2022; 770:136400.
10. Hashemzaei M, Mamoulakis C, Tsarouhas K, Georgiadis G, Lazopoulos G, Tsatsakis A, et al. Crocin: a fighter against inflammation and pain. Food Chem Toxicol 2020; 143:1-84.
11. Pashirzad M, Shafiee M, Avan A, Ryzhikov M, Fiuji H, Bahreyni A, et al. Therapeutic potency of crocin in the treatment of inflammatory diseases: current status and perspective. J Cell Physiol 2019; 234:14601-14611.
12. Wang X, Yuan B, Cheng B, Liu Y, Zhang B, Wang X, et al. Crocin alleviates myocardial ischemia/reperfusion-induced endoplasmic reticulum stress via regulation of miR-34a/Sirt1/Nrf2 pathway. Shock 2019; 51:123-130.
13. Aslani MR, Amani M, Masrori N, Boskabady MH, Ebrahimi HA, Chodari L. Crocin attenuates inflammation of lung tissue in ovalbumin-sensitized mice by altering the expression of endoplasmic reticulum stress markers. Biofactors 2021; 48:204-215.
14. Zhang H, Wu S, Yang Y, Su R, Wen J, Ke X, et al. Crocin protects human umbilical vein endothelial cells from high glucose-induced injury via inhibiting the endoplasmic reticulum stress response. Curr Mol Med 2018; 18:166-177.
15. Abou-Hany HO, Atef H, Said E, Elkashef HA, Salem HA. Crocin mediated amelioration of oxidative burden and inflammatory cascade suppresses diabetic nephropathy progression in diabetic rats. Chem Biol Interact 2018; 284:90-100.
16. Kim Y, Lim JH, Kim MY, Kim EN, Yoon HE, Shin SJ, et al. The adiponectin receptor agonist adipoRon ameliorates diabetic nephropathy in a model of type 2 diabetes. J Am Soc Nephrol 2018; 29:1108-1127.
17. Cai TT, Ye XL, Li RR, Chen H, Wang YY, Yong HJ, et al. Resveratrol modulates the gut microbiota and inflammation to protect against diabetic nephropathy in mice. Front Pharmacol 2020; 11:1-13.
18. Yaribeygi H, Mohammadi MT, Rezaee R, Sahebkar A. Crocin improves renal function by declining Nox-4, IL-18, and p53 expression levels in an experimental model of diabetic nephropathy. J cell Biochem 2018; 119:6080-6093.
19. Sankrityayan H, Oza MJ, Kulkarni YA, Mulay SR, Gaikwad AB. ER stress response mediates diabetic microvascular complications. Drug Discov Today 2019; 24:2247-2257.
20. Mather A, Pollock C. Glucose handling by the kidney. Kidney Int Suppl 2011; 120:1-6.
21. Chebotareva N, Vinogradov A, McDonnell V, Zakharova NV, Indeykina MI, Moiseev S, et al. Urinary protein and peptide markers in chronic kidney disease. Int J Mol Sci 2021; 22:1-20.
22. Gai Z, Wang T, Visentin M, Kullak-Ublick GA, Fu X, Wang Z. Lipid accumulation and chronic kidney disease. Nutrients 2019; 11:1-21.
23. Qu J, Zhu HH, Huang XJ, He GF, Liu JY, Huang JJ, et al. Abnormal indexes of liver and kidney injury markers predict severity in COVID-19 patients. Infect Drug Resist 2021; 14:3029-3040.
24. Margaritis I, Angelopoulou K, Lavrentiadou S, Mavrovouniotis IC, Tsantarliotou M, Taitzoglou I, et al. Effect of crocin on antioxidant gene expression, fibrinolytic parameters, redox status and blood biochemistry in nicotinamide-streptozotocin-induced diabetic rats. J Biol Res (Thessalon) 2020; 27:4-19.
25. Algandaby MM. Antifibrotic effects of crocin on thioacetamide-induced liver fibrosis in mice. Saudi J Biol Sci 2018; 25:747-754.
26. Qi C, Mao X, Zhang Z, Wu H. Classification and differential diagnosis of diabetic nephropathy. J Diabetes Res 2017; 2017:1-7.
27. Hou S, Zhang T, Li Y, Guo F, Jin X. Glycyrrhizic acid prevents diabetic nephropathy by activating AMPK/SIRT1/PGC-1α signaling in db/db mice. J Diabetes Res 2017; 2017:1-10.
28. Adali F, Gonul Y, Aldemir M, Hazman O, Ahsen A, Bozkurt MF, et al. Investigation of the effect of crocin pretreatment on renal injury induced by infrarenal aortic occlusion. J Surg Res 2016; 203:145-153.
29. Zhang L, Jing M, Liu Q. Crocin alleviates the inflammation and oxidative stress responses associated with diabetic nephropathy in rats via NLRP3 inflammasomes. Life Sci 2021; 278:1-9.
30. Yarijani ZM, Najafi H, Hamid Madani S. Protective effect of crocin on gentamicin-induced nephrotoxicity in rats. Iran J Basic Med Sci 2016; 19:337-343.
31. Xu S, He L, Ding K, Zhang L, Xu X, Wang S, et al. Tanshinone IIA ameliorates streptozotocin-induced diabetic nephropathy, partly by attenuating PERK pathway-induced fibrosis. Drug Des Devel Ther 2020; 14:5773-5782.
32. Yuan D, Liu XM, Fang Z, Du LL, Chang J, Lin SH. Protective effect of resveratrol on kidney in rats with diabetic nephropathy and its effect on endoplasmic reticulum stress. Eur Rev Med Pharmacol Sci 2018; 22:1485-1493.
33. Lin L, Liu G, Yang L. Crocin improves cognitive behavior in rats with alzheimer’s disease by regulating endoplasmic reticulum stress and apoptosis. Biomed Res Int 2019; 2019:1-9.
34. Jha JC, Banal C, Chow BS, Cooper ME, Jandeleit-Dahm K. Diabetes and kidney disease: role of oxidative stress. Antioxid Redox Signal 2016; 25:657-684.
35. Cerdá-Bernad D, Valero-Cases E, Pastor JJ, Frutos MJ. Saffron bioactives crocin, crocetin and safranal: effect on oxidative stress and mechanisms of action. Crit Rev Food Sci Nutr 2020; 62:3232-3249.
36. Victor P, Umapathy D, George L, Juttada U, Ganesh GV, Amin KN, et al. Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy. Cell Stress Chaperones 2021; 26:311-321.
37. He F, Ru X, Wen T. NRF2, a transcription factor for stress response and beyond. Int J Mol Sci 2020; 21:4777-4800.
38. Xing L, Guo H, Meng S, Zhu B, Fang J, Huang J, et al. Klotho ameliorates diabetic nephropathy by activating Nrf2 signaling pathway in podocytes. Biochem Biophys Res Commun 2021; 534:450-456.
39. Wang Y, Luo W, Wang Y. PARP-1 and its associated nucleases in DNA damage response. DNA Repair (Amst) 2019; 81:1-18.
40. Czabotar PE, Lessene G, Strasser A, Adams JM. Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat Rev Mol Cell Biol 2014; 15:49-63.
41. Cui FQ, Wang YF, Gao YB, Meng Y, Cai Z, Shen C, et al. Effects of BSF on podocyte apoptosis via regulating the ROS-mediated PI3K/AKT pathway in DN. J Diabetes Res 2019; 2019:1-10.
42. Qi Y, Chen L, Zhang L, Liu WB, Chen XY, Yang XG. Crocin prevents retinal ischaemia/reperfusion injury-induced apoptosis in retinal ganglion cells through the PI3K/AKT signalling pathway. Exp Eye Res 2013; 107:44-51.
43. Shen H, Ming Y, Xu C, Xu Y, Zhao S, Zhang Q. Deregulation of long noncoding RNA (TUG1) contributes to excessive podocytes apoptosis by activating endoplasmic reticulum stress in the development of diabetic nephropathy. J Cell Physiol 2019; 234:15123-15133.